KP Tissue Inc (TSE:KPT) – Equities researchers at National Bank Financial cut their FY2017 earnings per share (EPS) estimates for KP Tissue in a report issued on Thursday, according to Zacks Investment Research. National Bank Financial analyst L. Aghazarian now forecasts that the company will post earnings per share of $1.12 for the year, down from their previous forecast of $1.22. National Bank Financial also issued estimates for KP Tissue’s FY2018 earnings at $1.37 EPS.

ILLEGAL ACTIVITY NOTICE: This report was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at

Several other equities analysts have also recently commented on the stock. Scotiabank increased their price target on shares of KP Tissue from C$16.50 to C$18.50 and gave the stock an “outperform” rating in a research report on Friday, March 10th. Desjardins increased their price target on shares of KP Tissue from C$16.00 to C$18.50 in a research report on Friday, March 10th. Finally, TD Securities reaffirmed a “hold” rating and set a C$16.00 price target on shares of KP Tissue in a research report on Friday, May 5th.

KP Tissue (TSE:KPT) remained flat at $15.10 during mid-day trading on Monday. The stock had a trading volume of 400 shares. The stock has a 50 day moving average of $15.73 and a 200 day moving average of $15.36. KP Tissue has a 52-week low of $10.94 and a 52-week high of $16.34. The stock’s market capitalization is $138.18 million.

KP Tissue Company Profile

KP Tissue Inc is a Canada-based company, created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom and facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.

Get a free copy of the Zacks research report on KP Tissue (KPT)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Stock Ratings for KP Tissue Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue Inc and related stocks with our FREE daily email newsletter.